๐Ÿ“–
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
Shibuki T, Hoyek C, Ramaker R, Gottam M, Ueno M, Kawamoto Y, Itoh S, Inoue K, Hashimoto T, Fujisawa T, Imai M, Nakamura Y, Bando H, Pirozzi A, Zheng-Lin B, Abidoye O, Eslinger CR, Sonbol MB, Babiker H, Tran N, Morizane C, Strickler JH, Yoshino T, Bekaii-Saab T, Ikeda M

Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in J Gastroenterol.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
Author / Organization Shibuki T, Hoyek C, Ramaker R, Gottam M, Ueno M, Kawamoto Y, Itoh S, Inoue K, Hashimoto T, Fujisawa T, Imai M, Nakamura Y, Bando H, Pirozzi A, Zheng-Lin B, Abidoye O, Eslinger CR, Sonbol MB, Babiker H, Tran N, Morizane C, Strickler JH, Yoshino T, Bekaii-Saab T, Ikeda M
Subject & Discipline J Gastroenterol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6380
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »